Countries North America

Akamis Bio Reports Promising Early Efficacy For NG 350A In Rectal Cancer Study

NG-350A combined with chemoradiotherapy demonstrated promising efficacy and a favorable safety profile Composite response rate of 50 percent observed ac...

 April 21, 2026 | News

Orthogon Therapeutics Secures 11 Million Dollars To Advance First In Class Oral Therapy For BK Virus In Transplant Patients

Orthogon Therapeutics announced the closing of an $11 million follow-on financing, bringing the total capital raised to $36 million. The financing will ena...

 April 21, 2026 | News

EpiBiologics Advances Tissue Selective EGFR Degrader EPI 326 Into First In Human Clinical Study

First-in-human study of EPI-326 will evaluate the company’s lead tissue-selective EGFR degrader in patients with NSCLC and HNSCC with potential to ...

 April 21, 2026 | News

Synthetic Design Lab Introduces Logic Gated SYNTHBODY Platform Redefining Precision Protein Therapeutics

SYNTHBODY™ introduces a new class of “smart drugs”: protein therapeutics with built-in, multi-layered logic gates that actively chang...

 April 20, 2026 | News

Avantor Expands St Louis Quality Control Capabilities To Accelerate Biopharma Manufacturing

St. Louis site strengthens integrated support for biopharma manufacturing Avantor, Inc, a leading global provider of mission-critical products and ser...

 April 20, 2026 | News

DuPont Introduces Slurried AmberChrom XT Resins To Simplify Oligonucleotide And Peptide Purification

New slurried chromatography resins eliminate resin hydration step to help accelerate downstream purification of oligonucleotides and peptides DuPont annou...

 April 20, 2026 | News

Labcorp Launches First FDA Cleared Rapid Fentanyl Urine Test Made In The United States

First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams ...

 April 20, 2026 | News

Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...

 April 17, 2026 | News

Protaryx Medical Secures FDA 510(k) Clearance For Transseptal Puncture Device

Protaryx Medical, an innovative medical device company developing disruptive access solutions for minimally invasive left-heart procedures, announced that ...

 April 15, 2026 | News

VectorBuilder Introduces MuteFree AAV To Address ITR Instability In Gene Therapy Development

VectorBuilder, a global leader in gene delivery technologies and CDMO solutions, today announced MuteFree™ AAV, a high-stability AAV vector designed ...

 April 15, 2026 | News

Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...

 April 14, 2026 | News

GenScript Biotech Corporation And Mimulus Corp Collaborate To Industrialise DNA Based Data Storage

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Corp...

 April 14, 2026 | News

Vivatides Secures USD 54 Million Series A To Advance Next Generation RNA Therapeutics Beyond Liver Targets

Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies Vivatides Therapeutics, a global biotechnology ...

 April 13, 2026 | News

Biocon Limited Launches Bosaya And Aukelso In The United States To Expand Bone Health Access

Bosaya™ and Aukelso™ (both denosumab-kyqq products) now available in the United States, following U.S. FDA approval in September 2025 with ...

 April 10, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close